Institutional Exposure To Kazia Therapeutics Limited ADR (KZIA)
Kazia Therapeutics Limited ADR (KZIA) concluded trading on Wednesday at a closing price of $9.53, with 10.68 million shares of worth about $101.82 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 5.89% during that period and on July 09, 2025 the price saw […]
Is There More Upside Ahead For Kazia Therapeutics Limited ADR (NASDAQ: KZIA)
Kazia Therapeutics Limited ADR (KZIA) concluded trading on Wednesday at a closing price of $9.54, with 49.53 million shares of worth about $472.5 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -56.44% during that period and on June 11, 2025 the price saw […]
Is Kazia Therapeutics Limited ADR (NASDAQ: KZIA) Proving The Doubters Wrong?
Kazia Therapeutics Limited ADR (KZIA) concluded trading on Wednesday at a closing price of $0.32, with 20.42 million shares of worth about $6.53 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -65.97% during that period and on Wednesday the price saw a loss […]
Kazia Therapeutics Limited ADR (KZIA): Insights At A Glance
After grabbing 11639.0 shares, the institutional investor is now in possession of 11639.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.04% having worth around $5121.0. Moreover, BNP Paribas Financial Markets increased its share by 5202.0 to have a control over 8500.0 shares. And McGlone Suttner Wealth Management […]